48 results on '"Miksa M"'
Search Results
2. Abstract P-513
- Author
-
Miksa, M., primary
- Published
- 2018
- Full Text
- View/download PDF
3. New potent alpha(v)beta(3) integrin ligands based on azabicycloalkane (gamma,alpha)-dipeptide mimics
- Author
-
Pilkington-Miksa, M., Araldi, E. M. V., Arosio, D., Belvisi, L., Civera, M., and Manzoni, L.
- Subjects
ASSISTED DRUG-DELIVERY ,BIOLOGICAL EVALUATION ,MOLECULAR-MECHANICS ,BINDING ANALYSIS ,STRUCTURAL BASIS ,ANTAGONISTS ,PROTEINS ,DESIGN ,ANGIOGENESIS ,PEPTIDES - Abstract
We have designed a new synthetic strategy for the preparation of a new class of cyclic RGD integrin ligands in which the azabicycloalkane scaffold can be envisaged as a (gamma,alpha) dipeptide mimic. The synthesis and in vitro biological evaluation of these RGD derivatives, as well as the computational study of their conformational properties and binding modes to alpha(V)beta(3) integrin are described. Compound 3 has shown to be a promising candidate as alpha(V)beta(3) integrin antagonist able to interfere with both cell adhesion and movement on vitronectin with no evidence of cytotoxic effects.
- Published
- 2016
- Full Text
- View/download PDF
4. New potent αvβ3 integrin ligands based on azabicycloalkane (γ,α)-dipeptide mimics
- Author
-
Pilkington-Miksa, M., primary, Araldi, E. M. V., additional, Arosio, D., additional, Belvisi, L., additional, Civera, M., additional, and Manzoni, L., additional
- Published
- 2016
- Full Text
- View/download PDF
5. New potent αvβ3 integrin ligands based on azabicycloalkane (γ,α)-dipeptide mimics.
- Author
-
Pilkington-Miksa, M., Araldi, E. M. V., Arosio, D., Belvisi, L., Civera, M., and Manzoni, L.
- Published
- 2016
- Full Text
- View/download PDF
6. Immature dendritic cell-derived exosomes rescue septic animals via milk fat globule epidermal growth factor VIII
- Author
-
Miksa, M., primary, Wu, R., additional, Dong, W., additional, Komura, H., additional, Amin, D., additional, Ji, Y., additional, Wang, Z., additional, Wang, H., additional, Ravikumar, T. S., additional, Tracey, K. J., additional, and Wang, P., additional
- Published
- 2009
- Full Text
- View/download PDF
7. Erhöhte Sterblichkeit von Mäusen mit Lactadherinmangel in einer Sepsis: Rolle Verminderter Phagozytose Apoptotischer Zellen
- Author
-
Miksa, M, primary, Dong, D, additional, Wu, R, additional, Ravikumar, TS, additional, and Wang, P, additional
- Published
- 2007
- Full Text
- View/download PDF
8. DOWNREGULATION OF PROTEIN DISULFIDE ISOMERASE (PDI) IN SEPSIS AND ITS ROLE IN PROINFLAMMATORY CYTOKINE RELEASE
- Author
-
Zhou, M., primary, Ho, N., additional, Miksa, M., additional, Wu, R., additional, Cui, Y., additional, and Wang, P., additional
- Published
- 2006
- Full Text
- View/download PDF
9. GHRELIN INHIBITS SYMPATHETIC NERVOUS ACTIVITY IN SEPSIS
- Author
-
Wu, R., primary, Zhou, M., additional, Das, P., additional, Dong, W., additional, Ji, Y., additional, Yang, D., additional, Miksa, M., additional, Ravikumar, T.S., additional, and Wang, P., additional
- Published
- 2006
- Full Text
- View/download PDF
10. FRACTALKINE INCREASES APOPTOTIC CELL CLEARANCE BY UPREGULATING MFG-E8 IN MACROPHAGES
- Author
-
Miksa, M., primary, Amin, D., additional, Wu, R., additional, Ravikumar, T.S., additional, and Wang, P., additional
- Published
- 2006
- Full Text
- View/download PDF
11. ANTI-INFLAMMATORY EFFECTS OF ADRENOMEDULLIN (AM) AND ITS BINDING PROTEIN ARE MEDIATED BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ (PPAR-γ) THROUGH THE cAMP-DEPENDENT PATHWAY.
- Author
-
Miksa, M., primary, Wu, R., additional, Cui, X., additional, Simms, H. H., additional, and Wang, P., additional
- Published
- 2004
- Full Text
- View/download PDF
12. VX-166, a novel potent small molecule caspase inhibitor, as a promising new treatment for sepsis
- Author
-
Weber, P, Wang, P, Wu, R, Miksa, M, Dong, W, Ku, G, Dawson, D, Miller, K, and Charlton, P
- Subjects
Poster Presentation - Published
- 2006
13. Automatic movie ratings prediction using machine learning.
- Author
-
Marovic, M., Mihokovic, M., Miksa, M., Pribil, S., and Tus, A.
- Published
- 2011
14. Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion.
- Author
-
Cui T, Miksa M, Wu R, Komura H, Zhou M, Dong W, Wang Z, Higuchi S, Chaung W, Blau SA, Marini CP, Ravikumar TS, Wang P, Cui, Tianpen, Miksa, Michael, Wu, Rongqian, Komura, Hidefumi, Zhou, Mian, Dong, Weifeng, and Wang, Zhimin
- Abstract
Rationale: Milk fat globule epidermal growth factor 8 (MFG-E8) is a potent opsonin for the clearance of apoptotic cells and is produced by mononuclear cells of immune competent organs including the spleen and lungs. It attenuates chronic and acute inflammation such as autoimmune glomerulonephritis and bacterial sepsis by enhancing apoptotic cell clearance. Ischemia-reperfusion (I/R) injury of the gut results in severe inflammation, apoptosis, and remote organ damage, including acute lung injury (ALI).Objectives: To determine whether MFG-E8 attenuates intestinal and pulmonary inflammation after gut I/R.Methods: Wild-type (WT) and MFG-E8(-/-) mice underwent superior mesenteric artery occlusion for 90 minutes, followed by reperfusion for 4 hours. A group of WT mice was treated with 0.4 microg/20 g recombinant murine MFG-E8 (rmMFG-E8) at the beginning of reperfusion. Four hours after reperfusion, MFG-E8, cytokines, myeloperoxidase activity, apoptosis, and histopathology were assessed. A 24-hour survival study was conducted in rmMFG-E8- and vehicle-treated WT mice.Measurements and Main Results: Mesenteric I/R caused severe widespread injury and inflammation of the small intestines and remote organs, including the lungs. MFG-E8 levels decreased in the spleen and lungs by 50 to 60%, suggesting impaired apoptotic cell clearance. Treatment with rmMFG-E8 significantly suppressed inflammation (TNF-alpha, IL-6, IL-1beta, and myeloperoxidase) and injury of the lungs, liver, and kidneys. MFG-E8-deficient mice suffered from greatly increased inflammation and potentiated ALI, whereas treatment with rmMFG-E8 significantly improved the survival in WT mice.Conclusions: MFG-E8 attenuates inflammation and ALI after gut I/R and may represent a novel therapeutic agent. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
15. Importance of factors for ruggedness test in phase solubility analysis
- Author
-
Grdinic, V., Jaksevac-Miksa, M., Bezjak, A., and Radaic, A.
- Published
- 1994
- Full Text
- View/download PDF
16. Adverse Tracheal Intubation Events in Critically Ill Underweight and Obese Children: Retrospective Study of the National Emergency Airway for Children Registry (2013-2020).
- Author
-
Gladen KM, Tellez D, Napolitano N, Edwards LR, Sanders RC Jr, Kojima T, Malone MP, Shults J, Krawiec C, Ambati S, McCarthy R, Branca A, Polikoff LA, Jung P, Parsons SJ, Mallory PP, Komeswaran K, Page-Goertz C, Toal MC, Bysani GK, Meyer K, Chiusolo F, Glater-Welt LB, Al-Subu A, Biagas K, Hau Lee J, Miksa M, Giuliano JS Jr, Kierys KL, Talukdar AM, DeRusso M, Cucharme-Crevier L, Adu-Arko M, Shenoi AN, Kimura D, Flottman M, Gangu S, Freeman AD, Piehl MD, Nuthall GA, Tarquinio KM, Harwayne-Gidansky I, Hasegawa T, Rescoe ES, Breuer RK, Kasagi M, Nadkarni VM, and Nishisaki A
- Subjects
- Infant, Child, Humans, Infant, Newborn, Child, Preschool, Adolescent, Retrospective Studies, Overweight etiology, Thinness complications, Thinness epidemiology, Intubation, Intratracheal adverse effects, Intubation, Intratracheal methods, Hypoxia epidemiology, Hypoxia etiology, Registries, Critical Illness, Pediatric Obesity complications, Pediatric Obesity epidemiology
- Abstract
Objectives: Extremes of patient body mass index are associated with difficult intubation and increased morbidity in adults. We aimed to determine the association between being underweight or obese with adverse airway outcomes, including adverse tracheal intubation (TI)-associated events (TIAEs) and/or severe peri-intubation hypoxemia (pulse oximetry oxygen saturation < 80%) in critically ill children., Design/setting: Retrospective cohort using the National Emergency Airway for Children registry dataset of 2013-2020., Patients: Critically ill children, 0 to 17 years old, undergoing TI in PICUs., Interventions: None., Measurements and Main Results: Registry data from 24,342 patients who underwent TI between 2013 and 2020 were analyzed. Patients were categorized using the Centers for Disease Control and Prevention weight-for-age chart: normal weight (5th-84th percentile) 57.1%, underweight (< 5th percentile) 27.5%, overweight (85th to < 95th percentile) 7.2%, and obese (≥ 95th percentile) 8.2%. Underweight was most common in infants (34%); obesity was most common in children older than 8 years old (15.1%). Underweight patients more often had oxygenation and ventilation failure (34.0%, 36.2%, respectively) as the indication for TI and a history of difficult airway (16.7%). Apneic oxygenation was used more often in overweight and obese patients (19.1%, 19.6%) than in underweight or normal weight patients (14.1%, 17.1%; p < 0.001). TIAEs and/or hypoxemia occurred more often in underweight (27.1%) and obese (24.3%) patients ( p < 0.001). TI in underweight children was associated with greater odds of adverse airway outcome compared with normal weight children after adjusting for potential confounders (underweight: adjusted odds ratio [aOR], 1.09; 95% CI, 1.01-1.18; p = 0.016). Both underweight and obesity were associated with hypoxemia after adjusting for covariates and site clustering (underweight: aOR, 1.11; 95% CI, 1.02-1.21; p = 0.01 and obesity: aOR, 1.22; 95% CI, 1.07-1.39; p = 0.002)., Conclusions: In underweight and obese children compared with normal weight children, procedures around the timing of TI are associated with greater odds of adverse airway events., Competing Interests: Ms. Napolitano’s, Dr. Shults’s, Dr. Nadkarni’s, and Dr. Nishisaki’s institution received funding from the Agency for Healthcare Research and Quality (R18HS024511). Ms. Napolitano’s institution received funding from Dräger, Actuated Medical, and Philips Respironics; they received support for article research from Timpel and VERO-Biotech. Dr. Krawiec received funding from New England Journal of Medicine Healer Cases and Carle Illinois School of Medicine Admissions Committee. Dr. Polikoff received funding from Novavax. Dr. Lee’s institution received funding from National Research Medical Council, Singapore. Dr. Shenoi is an elected member of the Society of Critical Care Medicine (SCCM) Council of the SCCM. Dr. Peihl disclosed that he is founder and Chief Medical Officer of 410 Medical; his institution received funding the Department of Defense (grants: USSOCOM W81XWH-22-C-0002, USAF SBIR AF212-CSO1 Phase II, F2-15653 USAF, SBIR AF211-CSO1 Phase II, F2-15254). Dr. Hasegawa disclosed work for hire. Dr. Nishisaki’s institution received funding from Chiesi USA, AHRA, and the National Institute of Child Health and Human Development. The remaining authors have disclosed that they do not have any potential conflicts of interest., (Copyright © 2023 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.)
- Published
- 2024
- Full Text
- View/download PDF
17. Beyond Survival: Insights From the Phenotyping Sepsis-Induced Multiple Organ Failure Study on the Neurological Impact of Pediatric Sepsis.
- Author
-
Miksa M
- Subjects
- Child, Humans, Intensive Care Units, Pediatric, Multiple Organ Failure etiology, Sepsis complications
- Abstract
Competing Interests: Dr. Miksa has disclosed that he does not have any potential conflicts of interest.
- Published
- 2023
- Full Text
- View/download PDF
18. Implementation of a Critical Care Asthma Pathway in the PICU.
- Author
-
Miksa M, Kaushik S, Antovert G, Brown S, Ushay HM, and Katyal C
- Abstract
Objectives: Acute asthma management has improved significantly across hospitals in the United States due to implementation of standardized care pathways. Management of severe acute asthma in ICUs is less well studied, and variations in management may delay escalation and/or deescalation of therapies and increase length of stay. In order to standardize the management of severe acute asthma in our PICU, a nurse- and respiratory therapist-driven critical care asthma pathway was designed, implemented, and tested., Design: Cross-sectional study of severe acute asthma at baseline followed by implementation of a critical care asthma pathway., Setting: Twenty-six-bed urban quaternary PICU within a children's hospital., Patients: Patients 24 months to 18 years old admitted to the PICU in status asthmaticus. Patients with severe bacterial infections, chronic lung disease, heart disease, or immune disorders were excluded., Interventions: Implementation of a nurse- and respiratory therapist-driven respiratory scoring tool and critical care asthma pathway with explicit escalation/deescalation instructions., Measurements and Main Results: Primary outcome was PICU length of stay. Secondary outcomes were time to resolution of symptoms and hospital length of stay. Compliance approached 90% for respiratory score documentation and critical care asthma pathway adherence. Severity of illness at admission and clinical baseline characteristics were comparable in both groups. Pre intervention, the median ICU length of stay was 2 days (interquartile range, 1-3 d) with an overall hospital length of stay of 4 days (interquartile range, 3-6 d) ( n = 74). After implementation of the critical care asthma pathway, the ICU length of stay was 1 day (interquartile range, 1-2 d) ( p = 0.0013; n = 78) with an overall length of stay of 3 days (interquartile range, 2-3.75 d) ( p < 0.001). The time to resolution of symptoms was reduced from a median of 66.5 hours in the preintervention group to 21 hours in the postintervention compliant group ( p = 0.036)., Conclusions: The use of a structured critical care asthma pathway, driven by an ICU nurse and respiratory therapist, is associated with faster resolution of symptoms, decreased ICU, and overall hospital lengths of stay in children admitted to an ICU for severe acute asthma., Competing Interests: The authors have disclosed that they do not have any potential conflicts of interest., (Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.)
- Published
- 2021
- Full Text
- View/download PDF
19. Impact of Failure of Noninvasive Ventilation on the Safety of Pediatric Tracheal Intubation.
- Author
-
Emeriaud G, Napolitano N, Polikoff L, Giuliano J Jr, Toedt-Pingel I, Miksa M, Li S, Bysani K, Hsing DD, Nett S, Turner DA, Sanders RC Jr, Lee JH, Adu-Darko M, Owen EB, Gangadharan S, Parker M, Montgomery V, Craig N, Crulli B, Edwards L, Pinto M, Brunet F, Shults J, Nadkarni V, and Nishisaki A
- Subjects
- Adolescent, Child, Child, Preschool, Continuous Positive Airway Pressure, Humans, Infant, Prospective Studies, Young Adult, Critical Illness, Intensive Care Units, Pediatric statistics & numerical data, Intubation, Intratracheal adverse effects, Noninvasive Ventilation adverse effects, Oxygen blood
- Abstract
Objectives: Noninvasive ventilation is widely used to avoid tracheal intubation in critically ill children. The objective of this study was to assess whether noninvasive ventilation failure was associated with severe tracheal intubation-associated events and severe oxygen desaturation during tracheal intubation., Design: Prospective multicenter cohort study of consecutive intubated patients using the National Emergency Airway Registry for Children registry., Setting: Thirteen PICUs (in 12 institutions) in the United States and Canada., Patients: All patients undergoing tracheal intubation in participating sites were included. Noninvasive ventilation failure group included children with any use of high-flow nasal cannula, continuous positive airway pressure, or bilevel noninvasive ventilation in the 6 hours prior to tracheal intubation. Primary tracheal intubation group included children without exposure to noninvasive ventilation within 6 hours before tracheal intubation., Interventions: None., Measurements and Main Results: Severe tracheal intubation-associated events (cardiac arrest, esophageal intubation with delayed recognition, emesis with aspiration, hypotension requiring intervention, laryngospasm, pneumothorax, pneumomediastinum) and severe oxygen desaturation (< 70%) were recorded prospectively. The study included 956 tracheal intubation encounters; 424 tracheal intubations (44%) occurred after noninvasive ventilation failure, with a median of 13 hours (interquartile range, 4-38 hr) of noninvasive ventilation. Noninvasive ventilation failure group included more infants (47% vs 33%; p < 0.001) and patients with a respiratory diagnosis (56% vs 30%; p < 0.001). Noninvasive ventilation failure was not associated with severe tracheal intubation-associated events (5% vs 5% without noninvasive ventilation; p = 0.96) but was associated with severe desaturation (15% vs 9% without noninvasive ventilation; p = 0.005). After controlling for baseline differences, noninvasive ventilation failure was not independently associated with severe tracheal intubation-associated events (p = 0.35) or severe desaturation (p = 0.08). In the noninvasive ventilation failure group, higher FIO2 before tracheal intubation (≥ 70%) was associated with severe tracheal intubation-associated events., Conclusions: Critically ill children are frequently exposed to noninvasive ventilation before intubation. Noninvasive ventilation failure was not independently associated with severe tracheal intubation-associated events or severe oxygen desaturation compared to primary tracheal intubation.
- Published
- 2020
- Full Text
- View/download PDF
20. Protein biomarkers for incident deep venous thrombosis in critically ill adolescents: An exploratory study.
- Author
-
Tala JA, Polikoff LA, Pinto MG, Li S, Trakas E, Miksa M, Gertz S, and Faustino EVS
- Subjects
- Adolescent, Female, Follow-Up Studies, Humans, Incidence, Intensive Care Units, Male, Prognosis, Prospective Studies, Risk Factors, United States epidemiology, Venous Thrombosis blood, Venous Thrombosis epidemiology, Biomarkers blood, Critical Illness, Proteins analysis, Venous Thrombosis diagnosis
- Abstract
Background: There are no tests to identify critically ill children at high risk of deep venous thrombosis (DVT). In this exploratory study, we aimed to identify proteins that are associated with incident DVT in critically ill adolescents., Procedure: Plasma samples were obtained from critically ill adolescents within 24 hours after initiation of cardiopulmonary support. The adolescents were followed with ultrasound to detect the development of DVT of the lower extremity and clinically for bleeding. Thrombin-antithrombin complex and prothrombin fragment 1+2 were measured using immunosorbent assays, whereas procoagulation and anticoagulation factors were measured using multiplex assays. Plasma samples were also analyzed using SOMAscan, an aptamer-based capture assay. The associations between DVT and the log-transformed level of the proteins were assessed using logistic regression adjusting for the presence of femoral venous catheter and severity of illness. Associations were expressed as odds ratio (OR) for every log-fold increase in level of the protein with 95% confidence interval (CI)., Results: Plasma from 59 critically ill adolescents, of whom 9 developed incident DVT, was analyzed. The median age of the adolescents was 15.1 years (interquartile range, 14.0-16.7 years). Higher levels of thrombin-antithrombin complex (OR: 31.54; 95% CI: 2.09-475.92) and lower levels of factor XIII (OR: 0.03; 95% CI: 0.002-0.44) were associated with DVT. CD36, MIC-1, and EpoR were marginally associated with DVT. Only factor XIII was associated with clinically relevant bleeding (OR: 0.27; 95% CI: 0.08-0.97)., Conclusions: We identified candidate protein biomarkers for incident DVT. We plan to validate our findings in adequately powered studies., (© 2020 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
21. Epidemiology of Clinically Relevant Bleeding in Critically Ill Adolescents.
- Author
-
Pinto MG, Shabanova V, Li S, Trakas E, Miksa M, Gertz S, Polikoff LA, Tala JA, and Faustino EVS
- Subjects
- Adolescent, Anticoagulants therapeutic use, Critical Illness epidemiology, Female, Hemorrhage mortality, Humans, Male, Prospective Studies, Randomized Controlled Trials as Topic, Risk Factors, Venous Thromboembolism mortality, Venous Thromboembolism therapy, Venous Thrombosis epidemiology, Hemorrhage epidemiology, Intensive Care Units, Pediatric, Venous Thromboembolism epidemiology
- Abstract
Objectives: The epidemiology of clinically relevant bleeding in critically ill adolescents, particularly those who are at high risk of venous thromboembolism, is unclear. In preparation for a randomized clinical trial of pharmacologic prophylaxis against venous thromboembolism, we characterized the epidemiology of clinically relevant bleeding in critically ill adolescents., Design: Post hoc analysis of data from a pediatric multicenter observational study of venous thromboembolism., Setting: Six PICUs., Patients: Adolescents 13-17 years old who received cardiac or pulmonary support for at least 48 hours were eligible. Those admitted with venous thromboembolism or receiving therapeutic anticoagulation were excluded., Interventions: None., Measurements and Main Results: Adolescents (n = 88) were followed daily for the development of any bleeding event. The severity of the event was categorized based on the definitions by the International Society on Thrombosis and Haemostasis. The frequency of clinically relevant bleeding was 29.5% (95% CI, 20.3-40.2%) or 3.7 events (95% CI, 2.5-5.4 events) per 100 patient-days. Adolescents with venous thromboembolism were more likely to develop clinically relevant bleeding (hazard ratio, 2.06; 95% CI, 1.08-3.94). Age was negatively associated with clinically relevant bleeding (hazard ratio for every 1-year increase in age: 0.68; 95% CI, 0.58-0.79). In contrast, predicted risk of mortality (hazard ratio for every 0.10 increase in risk: 1.35; 95% CI, 1.05-1.74) and admission for trauma or surgery (hazard ratio: 2.04; 95% CI, 1.21-3.44) were positively associated with clinically relevant bleeding. The association of clinically relevant bleeding with medications, interventions, or laboratory tests, including mechanical ventilation and pharmacologic prophylaxis with anticoagulation, did not reach statistical significance. Adolescents with clinically relevant bleeding stayed in the hospital longer than those without clinically relevant bleeding., Conclusions: Clinically relevant bleeding is common in critically ill adolescents who are at high risk of venous thromboembolism. Admission for trauma or surgery can be used to stratify the risk of clinically relevant bleeding in these adolescents.
- Published
- 2019
- Full Text
- View/download PDF
22. Epidemiology of Lower Extremity Deep Venous Thrombosis in Critically Ill Adolescents.
- Author
-
Faustino EVS, Shabanova V, Pinto MG, Li S, Trakas E, Miksa M, Gertz S, Polikoff LA, Napolitano M, Brudnicki AR, Tala JA, and Silva CT
- Subjects
- Adolescent, Female, Follow-Up Studies, Humans, Incidence, Intensive Care Units statistics & numerical data, Male, Prospective Studies, Risk Factors, United States epidemiology, Venous Thrombosis drug therapy, Venous Thrombosis etiology, Critical Illness, Lower Extremity blood supply, Risk Assessment methods, Thrombolytic Therapy methods, Venous Thrombosis epidemiology
- Abstract
Objective: To determine the epidemiology of lower extremity deep venous thrombosis (DVT) in critically ill adolescents, which currently is unclear., Study Design: We performed a multicenter, prospective, cohort study. Adolescents aged 13-17 years who were admitted to 6 pediatric intensive care units and were anticipated to receive cardiopulmonary support for at least 48 hours were eligible, unless they were admitted with DVT or pulmonary embolism or were receiving or anticipated to receive therapeutic anticoagulation. While patients were in the unit, serial sonograms of the lower extremities were performed, then centrally adjudicated. Bayesian statistics were used to leverage the similarities between adults and adolescents., Results: A total of 88 adolescents were enrolled, from whom 184 lower extremity sonograms were performed. Of these, 9 adolescents developed DVT, with 1 having bilateral DVT. The frequency of DVT was 12.4% (95% credible interval: 6.1%, 20.1%), which ranged from 6.3% to 19.8% with a variability of 41.0% across units. All cases of DVT occurred in adolescents who received invasive mechanical ventilation (frequency: 16.5%; 95% credible interval 8.1%, 26.6%). DVT was associated with femoral central venous catheterization (OR 15.44; 95% credible interval 1.62, 69.05) and severe illness (OR for every 0.1 increase in risk of mortality 3.11; 95% credible interval 1.19, 6.85). DVT appears to be associated with prolonged days on support., Conclusions: Our findings highlight the similarities and differences in the epidemiology of DVT between adults and adolescents. They support the conduct and inform the design of a trial of pharmacologic prophylaxis in critically ill adolescents., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
23. Safety of tracheal intubation in the presence of cardiac disease in paediatric ICUs.
- Author
-
Gradidge EA, Bakar A, Tellez D, Ruppe M, Tallent S, Bird G, Lavin N, Lee A, Nadkarni V, Adu-Darko M, Bain J, Biagas K, Branca A, Breuer RK, Brown C, Bysani K, Emeriaud G, Gangadharan S, Giuliano JS, Howell JD, Krawiec C, Lee JH, Li S, Meyer K, Miksa M, Napolitano N, Nett S, Nuthall G, Orioles A, Owen EB, Parker MM, Parsons S, Polikoff LA, Rehder K, Saito O, Sanders RC, Shenoi A, Simon DW, Skippen PW, Tarquinio K, Thompson A, Toedt-Pingel I, Walson K, and Nishisaki A
- Subjects
- Child, Child, Preschool, Female, Heart Arrest prevention & control, Humans, Incidence, Infant, Infant, Newborn, Logistic Models, Male, Quality Improvement organization & administration, Registries, Retrospective Studies, Risk Factors, Heart Arrest epidemiology, Intensive Care Units, Pediatric, Intubation, Intratracheal adverse effects
- Abstract
IntroductionChildren with CHD and acquired heart disease have unique, high-risk physiology. They may have a higher risk of adverse tracheal-intubation-associated events, as compared with children with non-cardiac disease.Materials and methodsWe sought to evaluate the occurrence of adverse tracheal-intubation-associated events in children with cardiac disease compared to children with non-cardiac disease. A retrospective analysis of tracheal intubations from 38 international paediatric ICUs was performed using the National Emergency Airway Registry for Children (NEAR4KIDS) quality improvement registry. The primary outcome was the occurrence of any tracheal-intubation-associated event. Secondary outcomes included the occurrence of severe tracheal-intubation-associated events, multiple intubation attempts, and oxygen desaturation., Results: A total of 8851 intubations were reported between July, 2012 and March, 2016. Cardiac patients were younger, more likely to have haemodynamic instability, and less likely to have respiratory failure as an indication. The overall frequency of tracheal-intubation-associated events was not different (cardiac: 17% versus non-cardiac: 16%, p=0.13), nor was the rate of severe tracheal-intubation-associated events (cardiac: 7% versus non-cardiac: 6%, p=0.11). Tracheal-intubation-associated cardiac arrest occurred more often in cardiac patients (2.80 versus 1.28%; p<0.001), even after adjusting for patient and provider differences (adjusted odds ratio 1.79; p=0.03). Multiple intubation attempts occurred less often in cardiac patients (p=0.04), and oxygen desaturations occurred more often, even after excluding patients with cyanotic heart disease., Conclusions: The overall incidence of adverse tracheal-intubation-associated events in cardiac patients was not different from that in non-cardiac patients. However, the presence of a cardiac diagnosis was associated with a higher occurrence of both tracheal-intubation-associated cardiac arrest and oxygen desaturation.
- Published
- 2018
- Full Text
- View/download PDF
24. Effect of Location on Tracheal Intubation Safety in Cardiac Disease-Are Cardiac ICUs Safer?
- Author
-
Gradidge EA, Bakar A, Tellez D, Ruppe M, Tallent S, Bird G, Lavin N, Lee A, Adu-Darko M, Bain J, Biagas K, Branca A, Breuer RK, Brown C 3rd, Bysani GK, Cheifitz IM, Emeriaud G, Gangadharan S, Giuliano JS Jr, Howell JD, Krawiec C, Lee JH, Li S, Meyer K, Miksa M, Napolitano N, Nett S, Nuthall G, Orioles A, Owen EB, Parker MM, Parsons S, Polikoff LA, Rehder K, Saito O, Sanders RC Jr, Shenoi AN, Simon DW, Skippen PW, Tarquinio K, Thompson A, Toedt-Pingel I, Vanderford P, Walson K, Nadkarni V, and Nishisaki A
- Subjects
- Adolescent, Child, Child, Preschool, Cohort Studies, Databases, Factual, Female, Humans, Infant, Infant, Newborn, Intubation, Intratracheal statistics & numerical data, Male, Oximetry statistics & numerical data, Quality Improvement, Retrospective Studies, Critical Illness therapy, Heart Diseases therapy, Intensive Care Units, Pediatric statistics & numerical data, Intubation, Intratracheal adverse effects, Practice Patterns, Physicians' statistics & numerical data
- Abstract
Objectives: Evaluate differences in tracheal intubation-associated events and process variances (i.e., multiple intubation attempts and oxygen desaturation) between pediatric cardiac ICUs and noncardiac PICUs in children with underlying cardiac disease., Design: Retrospective cohort study using a multicenter tracheal intubation quality improvement database (National Emergency Airway Registry for Children)., Setting: Thirty-six PICUs (five cardiac ICUs, 31 noncardiac ICUs) from July 2012 to March 2016., Patients: Children with medical or surgical cardiac disease who underwent intubation in an ICU., Interventions: None., Measurements and Main Results: Our primary outcome was the rate of any adverse tracheal intubation-associated event. Secondary outcomes were severe tracheal intubation-associated events, multiple tracheal intubation attempt rates, and oxygen desaturation. There were 1,502 tracheal intubations in children with underlying cardiac disease (751 in cardiac ICUs, 751 in noncardiac ICUs) reported. Cardiac ICUs and noncardiac ICUs had similar proportions of patients with surgical cardiac disease. Patients undergoing intubation in cardiac ICUs were younger (median age, 1 mo [interquartile range, 0-6 mo]) compared with noncardiac ICUs (median 3 mo [interquartile range, 1-11 mo]; p < 0.001). Tracheal intubation-associated event rates were not different between cardiac ICUs and noncardiac ICUs (16% vs 19%; adjusted odds ratio, 0.74; 95% CI, 0.54-1.02; p = 0.069). However, in a sensitivity analysis comparing cardiac ICUs with mixed ICUs (i.e., ICUs caring for children with either general pediatric or cardiac diseases), cardiac ICUs had decreased odds of adverse events (adjusted odds ratio, 0.71; 95% CI, 0.52-0.97; p = 0.033). Rates of severe tracheal intubation-associated events and multiple attempts were similar. Desaturations occurred more often during intubation in cardiac ICUs (adjusted odds ratio, 1.61; 95% CI, 1.04-1.15; p = 0.002)., Conclusions: In children with underlying cardiac disease, rates of adverse tracheal intubation-associated events were not lower in cardiac ICUs as compared to noncardiac ICUs, even after adjusting for differences in patient characteristics and care models.
- Published
- 2018
- Full Text
- View/download PDF
25. Frequency of Desaturation and Association With Hemodynamic Adverse Events During Tracheal Intubations in PICUs.
- Author
-
Li S, Hsieh TC, Rehder KJ, Nett S, Kamat P, Napolitano N, Turner DA, Adu-Darko M, Jarvis JD, Krawiec C, Derbyshire AT, Meyer K, Giuliano JS Jr, Tala J, Tarquinio K, Ruppe MD, Sanders RC Jr, Pinto M, Howell JD, Parker MM, Nuthall G, Shepherd M, Emeriaud G, Nagai Y, Saito O, Lee JH, Simon DW, Orioles A, Walson K, Vanderford P, Shenoi A, Lee A, Bird GL, Miksa M, Graciano AL, Bain J, Skippen PW, Polikoff LA, Nadkarni V, and Nishisaki A
- Subjects
- Adolescent, Child, Child, Preschool, Cohort Studies, Female, Humans, Hypoxia etiology, Infant, Intensive Care Units, Pediatric statistics & numerical data, Male, Quality Improvement, Registries, Retrospective Studies, Critical Illness therapy, Hemodynamics physiology, Hypoxia epidemiology, Intubation, Intratracheal adverse effects, Oxygen blood
- Abstract
Objectives: Oxygen desaturation during tracheal intubation is known to be associated with adverse ICU outcomes in critically ill children. We aimed to determine the occurrence and severity of desaturation during tracheal intubations and the association with adverse hemodynamic tracheal intubation-associated events., Design: Retrospective cohort study as a part of the National Emergency Airway Registry for Children Network's quality improvement project from January 2012 to December 2014., Setting: International PICUs., Patients: Critically ill children younger than 18 years undergoing primary tracheal intubations in the ICUs., Interventions: tracheal intubation processes of care and outcomes were prospectively collected using standardized operational definitions. We defined moderate desaturation as oxygen saturation less than 80% and severe desaturation as oxygen saturation less than 70% during tracheal intubation procedures in children with initial oxygen saturation greater than 90% after preoxygenation. Adverse hemodynamic tracheal intubation-associated event was defined as cardiac arrests, hypo or hypertension requiring intervention, and dysrhythmia., Measurements and Main Results: A total of 5,498 primary tracheal intubations from 31 ICUs were reported. Moderate desaturation was observed in 19.3% associated with adverse hemodynamic tracheal intubation-associated events (9.8% among children with moderate desaturation vs 4.4% without desaturation; p < 0.001). Severe desaturation was observed in 12.9% of tracheal intubations, also significantly associated with hemodynamic tracheal intubation-associated events. After adjusting for patient, provider, and practice factors, the occurrence of moderate desaturation was independently associated with hemodynamic tracheal intubation-associated events: adjusted odds ratio 1.83 (95% CI, 1.34-2.51; p < 0.001). The occurrence of severe desaturation was also independently associated with hemodynamic tracheal intubation-associated events: adjusted odds ratio 2.16 (95% CI, 1.54-3.04; p < 0.001). Number of tracheal intubation attempts was also significantly associated with the frequency of moderate and severe desaturations (p < 0.001)., Conclusions: In this large tracheal intubation quality improvement database, we found moderate and severe desaturation are reported among 19% and 13% of all tracheal intubation encounters. Moderate and severe desaturations were independently associated with the occurrence of adverse hemodynamic events. Future quality improvement interventions may focus to reduce desaturation events.
- Published
- 2018
- Full Text
- View/download PDF
26. Trend and Outcomes of Video Laryngoscope Use Across PICUs.
- Author
-
Grunwell JR, Kamat PP, Miksa M, Krishna A, Walson K, Simon D, Krawiec C, Breuer R, Lee JH, Gradidge E, Tarquinio K, Shenoi A, Shults J, Nadkarni V, and Nishisaki A
- Subjects
- Adolescent, Canada, Child, Child, Preschool, Databases, Factual, Female, Humans, Infant, Infant, Newborn, Intubation, Intratracheal adverse effects, Intubation, Intratracheal instrumentation, Intubation, Intratracheal trends, Japan, Laryngoscopes, Laryngoscopy adverse effects, Laryngoscopy instrumentation, Laryngoscopy trends, Logistic Models, Male, New Zealand, Retrospective Studies, Singapore, United States, Video Recording trends, Intensive Care Units, Pediatric trends, Intubation, Intratracheal methods, Laryngoscopy methods, Practice Patterns, Physicians' trends, Video Recording statistics & numerical data
- Abstract
Objective: Video (indirect) laryngoscopy is used as a primary tracheal intubation device for difficult airways in emergency departments and in adult ICUs. The use and outcomes of video laryngoscopy compared with direct laryngoscopy has not been quantified in PICUs or cardiac ICUs., Design: Retrospective review of prospectively collected observational data from a multicenter tracheal intubation database (National Emergency Airway Registry for Children) from July 2010 to June 2015., Setting: Thirty-six PICUs/cardiac ICUs across the United States, Canada, Japan, New Zealand, and Singapore., Patients: Any patient admitted to a PICU or a pediatric cardiac ICU and undergoing tracheal intubation., Interventions: Use of direct laryngoscopy versus video laryngoscopy for tracheal intubation., Measurements and Main Results: There were 8,875 tracheal intubations reported in the National Emergency Airway Registry for Children database, including 7,947 (89.5%) tracheal intubations performed using direct laryngoscopy and 928 (10.5%) tracheal intubations performed using video laryngoscopy. Wide variability in video laryngoscopy use exists across PICUs (median, 2.6%; range, 0-55%). Video laryngoscopy was more often used in older children (p < 0.001), in children with history of a difficult airway (p = 0.01), in children intubated for ventilatory failure (p < 0.001), and to facilitate the completion of an elective procedure (p = 0.048). After adjusting for patient-level covariates, a secular trend, and site-level variance, the use of video laryngoscopy significantly increased over a 5-year period compared with fiscal year 2011 (odds ratio, 6.7; 95% CI, 1.7-26.8 for fiscal year 2014 and odds ratio, 11.2; 95% CI, 3.2-38.9 for fiscal year 2015). The use of video laryngoscopy was independently associated with a lower occurrence of tracheal intubation adverse events (adjusted odds ratio, 0.57; 95% CI, 0.42-0.77; p < 0.001) but not with a lower occurrence of severe tracheal intubation adverse events (adjusted odds ratio, 0.86; 95% CI, 0.56-1.32; p = 0.49) or fewer multiple attempts at endotracheal intubation (adjusted odds ratio, 0.93; 95% CI, 0.71-1.22; p = 0.59)., Conclusions: Using National Emergency Airway Registry for Children data, we described patient-centered adverse outcomes associated with video laryngoscopy compared with direct laryngoscopy for tracheal intubation in the largest reported international cohort of children to date. Data from this study may be used to design sufficiently powered prospective studies comparing patient-centered outcomes for video laryngoscopy versus direct laryngoscopy during endotracheal intubation.
- Published
- 2017
- Full Text
- View/download PDF
27. Relationship Between Adverse Tracheal Intubation Associated Events and PICU Outcomes.
- Author
-
Parker MM, Nuthall G, Brown C 3rd, Biagas K, Napolitano N, Polikoff LA, Simon D, Miksa M, Gradidge E, Lee JH, Krishna AS, Tellez D, Bird GL, Rehder KJ, Turner DA, Adu-Darko M, Nett ST, Derbyshire AT, Meyer K, Giuliano J Jr, Owen EB, Sullivan JE, Tarquinio K, Kamat P, Sanders RC Jr, Pinto M, Bysani GK, Emeriaud G, Nagai Y, McCarthy MA, Walson KH, Vanderford P, Lee A, Bain J, Skippen P, Breuer R, Tallent S, Nadkarni V, and Nishisaki A
- Subjects
- Adolescent, Child, Child, Preschool, Critical Illness, Databases, Factual, Female, Humans, Infant, Infant, Newborn, Intubation, Intratracheal mortality, Male, Multivariate Analysis, Outcome Assessment, Health Care, Quality Improvement, Retrospective Studies, Hospital Mortality, Intensive Care Units, Pediatric statistics & numerical data, Intubation, Intratracheal adverse effects, Length of Stay statistics & numerical data, Respiration, Artificial statistics & numerical data
- Abstract
Objective: Tracheal intubation in PICUs is a common procedure often associated with adverse events. The aim of this study is to evaluate the association between immediate events such as tracheal intubation associated events or desaturation and ICU outcomes: length of stay, duration of mechanical ventilation, and mortality., Study Design: Prospective cohort study with 35 PICUs using a multicenter tracheal intubation quality improvement database (National Emergency Airway Registry for Children: NEAR4KIDS) from January 2013 to June 2015. Desaturation defined as Spo2 less than 80%., Setting: PICUs participating in NEAR4KIDS., Patients: All patients less than18 years of age undergoing primary tracheal intubations with ICU outcome data were analyzed., Measurements and Main Results: Five thousand five hundred four tracheal intubation encounters with median 108 (interquartile range, 58-229) tracheal intubations per site. At least one tracheal intubation associated event was reported in 892 (16%), with 364 (6.6%) severe tracheal intubation associated events. Infants had a higher frequency of tracheal intubation associated event or desaturation than older patients (48% infants vs 34% for 1-7 yr and 18% for 8-17 yr). In univariate analysis, the occurrence of tracheal intubation associated event or desaturation was associated with a longer mechanical ventilation (5 vs 3 d; p < 0.001) and longer PICU stay (14 vs 11 d; p < 0.001) but not with PICU mortality. The occurrence of severe tracheal intubation associated events was associated with longer mechanical ventilation (5 vs 4 d; p < 0.003), longer PICU stay (15 vs 12 d; p < 0.035), and PICU mortality (19.9% vs 9.6%; p < 0.0001). In multivariable analyses, the occurrence of tracheal intubation associated event or desaturation was significantly associated with longer mechanical ventilation (+12%; 95% CI, 4-21%; p = 0.004), and severe tracheal intubation associated events were independently associated with increased PICU mortality (OR = 1.80; 95% CI, 1.24-2.60; p = 0.002), after adjusted for patient confounders., Conclusions: Adverse tracheal intubation associated events and desaturations are common and associated with longer mechanical ventilation in critically ill children. Severe tracheal intubation associated events are associated with higher ICU mortality. Potential interventions to decrease tracheal intubation associated events and oxygen desaturation, such as tracheal intubation checklist, use of apneic oxygenation, and video laryngoscopy, may need to be considered to improve ICU outcomes.
- Published
- 2017
- Full Text
- View/download PDF
28. Pulmonary Alveolar Proteinosis in Association with Secondary Hemophagocytic Lymphohistiocytosis.
- Author
-
Lin J, De A, Figueiredo L, Maxwell R, Wasserman E, Adams K, Weingarten J, Peek G, and Miksa M
- Subjects
- Abnormalities, Multiple diagnosis, Abnormalities, Multiple therapy, Biopsy, Needle, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Immunohistochemistry, Infant, Lymphohistiocytosis, Hemophagocytic complications, Pulmonary Alveolar Proteinosis complications, Radiography, Thoracic methods, Rare Diseases, Respiration, Artificial, Respiratory Insufficiency diagnosis, Respiratory Insufficiency etiology, Respiratory Insufficiency therapy, Risk Assessment, Severity of Illness Index, Tomography, X-Ray Computed methods, Tracheostomy methods, Treatment Outcome, Lymphohistiocytosis, Hemophagocytic diagnosis, Lymphohistiocytosis, Hemophagocytic therapy, Pulmonary Alveolar Proteinosis diagnosis, Pulmonary Alveolar Proteinosis therapy
- Abstract
Pulmonary alveolar proteinosis (PAP) is a rare diffuse lung disease in the pediatric population. There are currently few cases documenting hemophagocytic lymphohistiocytosis as a cause for secondary PAP. We describe an ex-preterm child with secondary hemophagocytic lymphohistiocytosis, complicated by PAP and hypoxemic respiratory failure., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
29. Heterogeneity of manufacturers' declarations for lipemia interference--an urgent call for standardization.
- Author
-
Nikolac N, Simundic AM, Miksa M, Lima-Oliveira G, Salvagno GL, Caruso B, and Guidi GC
- Subjects
- Humans, Reproducibility of Results, Clinical Chemistry Tests standards, Clinical Laboratory Services standards, Hyperlipidemias blood
- Abstract
Introduction: Due to the budget limitations, laboratories mostly rely on the manufacturers' information about the influence of interfering substances on laboratory results. However, some manufacturers do not follow the recommended procedures for testing interferences (CLSI standard) and there is a great variability in the presentation of data regarding lipemia interference., Materials and Methods: We aimed to verify the manufacturers' specifications for lipemia interference for clinical chemistry reagents provided by Beckman Coulter, Roche and Siemens. Bias was determined using the Intralipid® simulated lipemic samples. Furthermore, we aimed to compare obtained data with the manufacturers' claims and desirable specification for imprecision derived from biological variation., Results: i) Manufacturers' declarations were not confirmed for all three manufacturers; ii) the magnitude and direction of the effect of lipemia on laboratory results differ substantially between the three tested analytical systems; and iii) manufacturers are using arbitrary limits in declaring the expected effect of interference on laboratory results., Conclusions: There is an urgent need to standardize the way manufacturers test and report their data on the lipemia interference. We propose that, instead of arbitrary limits, manufacturers use evidence based quality specifications for assessing the allowable biases. Moreover, laboratories should be aware of the possible lack of replicability of manufacturers' declarations., (© 2013.)
- Published
- 2013
- Full Text
- View/download PDF
30. Control of serum glucose concentration in critical illness.
- Author
-
Kandil SB, Miksa M, and Faustino EV
- Subjects
- Child, Humans, Hyperglycemia blood, Hyperglycemia prevention & control, Hypoglycemia chemically induced, Hypoglycemic Agents adverse effects, Blood Glucose metabolism, Critical Illness therapy, Hypoglycemic Agents therapeutic use
- Abstract
Purpose of Review: Hyperglycemia is a significant problem for children in the ICU. Use of tight glycemic control (TGC) to manage hyperglycemia remains controversial, especially given the potential risk of insulin-induced hypoglycemia. This review will address the latest evidence regarding TGC in critically ill children., Recent Findings: Two randomized controlled trials (RCT) involving primarily postoperative cardiac surgery patients demonstrated the feasibility and safety of TGC in pediatric patients. The trials, however, had discrepant results with regards to the benefit of TGC. There is also uncertainty about the generalizability of these results to nonpostoperative cardiac patients. There is only one published study addressing the long-term safety of TGC in children. In this study, hypoglycemia was not associated with adverse effects on neurocognitive development. In contrast, articles from adult studies demonstrate increased risk of death with hypoglycemia., Summary: Although the clinical benefit of TGC in critically ill children is still unclear, TGC can be done safely in this population.
- Published
- 2013
- Full Text
- View/download PDF
31. Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
- Author
-
Pilkington-Miksa M, Arosio D, Battistini L, Belvisi L, De Matteo M, Vasile F, Burreddu P, Carta P, Rassu G, Perego P, Carenini N, Zunino F, De Cesare M, Castiglioni V, Scanziani E, Scolastico C, Casiraghi G, Zanardi F, and Manzoni L
- Subjects
- Amides chemistry, Animals, Antineoplastic Agents pharmacology, Azabicyclo Compounds chemistry, Calibration, Cell Line, Tumor, Chemistry Techniques, Synthetic, Drug Carriers chemistry, Drug Carriers metabolism, Female, Humans, Inhibitory Concentration 50, Mice, Paclitaxel pharmacology, Peptides, Cyclic chemistry, Peptides, Cyclic metabolism, Proline analogs & derivatives, Proline chemistry, Xenograft Model Antitumor Assays, Antineoplastic Agents chemistry, Drug Carriers chemical synthesis, Drug Design, Integrin alphaVbeta3 metabolism, Paclitaxel chemistry, Peptides, Cyclic chemical synthesis, Receptors, Vitronectin metabolism
- Abstract
The efficacy of taxane-based antitumor therapy is limited by several drawbacks which result in a poor therapeutic index. Thus, the development of approaches that favor selective delivery of taxane drugs (e.g., paclitaxel, PTX) to the disease area represents a truly challenging goal. On the basis of the strategic role of integrins in tumor cell survival and tumor progression, as well as on integrin expression in tumors, novel molecular conjugates were prepared where PTX is covalently attached to either cyclic AbaRGD (Azabicycloalkane-RGD) or AmproRGD (Aminoproline-RGD) integrin-recognizing matrices via structurally diverse connections. Receptor-binding assays indicated satisfactory-to-excellent α(V)β(3) binding capabilities for most conjugates, while in vitro growth inhibition assays on a panel of human tumor cell lines revealed outstanding cell sensitivity values. Among the nine conjugate ensemble, derivative 21, bearing a robust triazole ring connected to ethylene glycol units by an amide function and showing excellent cell sensitivity properties, was selected for in vivo studies in an ovarian carcinoma model xenografted in immunodeficient mice. Remarkable antitumor activity was attained, superior to that of PTX itself, which was associated with a marked induction of aberrant mitoses, consistent with the mechanism of action of spindle poisons. Overall, the novel cRGD-PTX conjugates disclosed here represent promising candidates for further advancement in the domain of targeted antitumor therapy.
- Published
- 2012
- Full Text
- View/download PDF
32. Synthesis of Gd and (68)Ga complexes in conjugation with a conformationally optimized RGD sequence as potential MRI and PET tumor-imaging probes.
- Author
-
Manzoni L, Belvisi L, Arosio D, Bartolomeo MP, Bianchi A, Brioschi C, Buonsanti F, Cabella C, Casagrande C, Civera M, De Matteo M, Fugazza L, Lattuada L, Maisano F, Miragoli L, Neira C, Pilkington-Miksa M, and Scolastico C
- Subjects
- Animals, Cell Line, Tumor, Coordination Complexes chemistry, Gadolinium chemistry, Gallium Radioisotopes chemistry, Glioblastoma diagnostic imaging, Humans, Magnetic Resonance Imaging, Mice, Mice, Nude, Models, Molecular, Oligopeptides metabolism, Positron-Emission Tomography, Protein Binding, Radiopharmaceuticals chemistry, Transplantation, Heterologous, Coordination Complexes chemical synthesis, Oligopeptides chemistry, Radiopharmaceuticals chemical synthesis
- Abstract
We report the synthesis of novel chelates of Gd and (68)Ga with DPTA, DOTA, HP-DOA3, as well as with AAZTA, a novel chelating agent developed by our research group. These chelating agents were appropriately conjugated, prior to metal complexation, with DB58, an RGD peptidomimetic, conformationally constrained on an azabicycloalkane scaffold and endowed with high affinity for integrin α(ν)β(3) . Because α(ν)β(3) is involved in neo-angiogenesis in solid tumors and is also directly expressed in cancer cells (e.g. glioblastomas, melanomas) and ovarian, breast, and prostate cancers, these constructs could prove useful as molecular imaging probes in cancer diagnosis by MRI or PET techniques. Molecular modeling, integrin binding assays, and relaxivity assessments allowed the selection of compounds suitable for multiple expression on dendrimeric or nanoparticulate structures. These results also led us to an exploratory investigation of (68)Ga complexation for the promising (68)Ga-PET technique; the AAZTA complex 15((68)Ga) exhibited uptake in a xenograft model of glioblastoma, suggesting potentially useful developments with new probes with improved affinity., (Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2012
- Full Text
- View/download PDF
33. Immature dendritic cell-derived exosomes rescue septic animals via milk fat globule epidermal growth factor-factor VIII [corrected].
- Author
-
Miksa M, Wu R, Dong W, Komura H, Amin D, Ji Y, Wang Z, Wang H, Ravikumar TS, Tracey KJ, and Wang P
- Subjects
- Animals, Antigens, Surface administration & dosage, Apoptosis Regulatory Proteins administration & dosage, Apoptosis Regulatory Proteins antagonists & inhibitors, Apoptosis Regulatory Proteins physiology, Cells, Cultured, Dendritic Cells pathology, Inflammation Mediators administration & dosage, Inflammation Mediators antagonists & inhibitors, Inflammation Mediators physiology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Milk Proteins administration & dosage, Milk Proteins antagonists & inhibitors, Rats, Rats, Sprague-Dawley, Recombinant Proteins administration & dosage, Sepsis immunology, Sepsis pathology, Antigens, Surface physiology, Cell Differentiation immunology, Dendritic Cells cytology, Dendritic Cells immunology, Exosomes immunology, Exosomes metabolism, Sepsis metabolism, Sepsis therapy
- Abstract
Sepsis, a highly lethal systemic inflammatory syndrome, is associated with increases of proinflammatory cytokines (e.g., TNF-alpha, HMGB1) and the accumulation of apoptotic cells that have the potential to be detrimental. Depending on the timing and tissue, prevention of apoptosis in sepsis is beneficial; however, thwarting the development of secondary necrosis through the active removal of apoptotic cells by phagocytosis may offer a novel anti-sepsis therapy. Immature dendritic cells (IDCs) release exosomes that contain milk fat globule EGF factor VIII (MFGE8), a protein required to opsonize apoptotic cells for phagocytosis. In an experimental sepsis model using cecal ligation and puncture, we found that MFGE8 levels decreased in the spleen and blood, which was associated with impaired apoptotic cell clearance. Administration of IDC-derived exosomes promoted phagocytosis of apoptotic cells and significantly reduced mortality. Treatment with recombinant MFGE8 was equally protective, whereas MFGE8-deficient mice suffered from increased mortality. IDC exosomes also attenuated the release of proinflammatory cytokines in septic rats. Liberation of HMGB1, a nuclear protein that contributes to inflammation upon release from unengulfed apoptotic cells, was prevented by MFGE8-mediated phagocytosis in vitro. We conclude that IDC-derived exosomes attenuate the acute systemic inflammatory response in sepsis by enhancing apoptotic cell clearance via MFGE8.
- Published
- 2009
- Full Text
- View/download PDF
34. Ghrelin hyporesponsiveness contributes to age-related hyperinflammation in septic shock.
- Author
-
Wu R, Zhou M, Dong W, Ji Y, Miksa M, Marini CP, Ravikumar TS, and Wang P
- Subjects
- Age Factors, Animals, Cells, Cultured, Disease Models, Animal, Ghrelin blood, Male, Rats, Rats, Inbred F344, Brain physiology, Ghrelin metabolism, Growth Hormone metabolism, Inflammation physiopathology, Shock, Septic physiopathology
- Abstract
Objective: To test the hypothesis that hyporesponsiveness to ghrelin due to reduced growth hormone (GH) contributes to the aging-related hyperinflammatory state in sepsis., Summary Background Data: Sepsis and septic shock are a serious problem, particularly in the geriatric population. Ghrelin is an endogenous ligand for the GH secretagogue receptor 1a (GHSR1a, ie, ghrelin receptor). The decline in GH with age is directly associated with many adverse changes that occur with aging. However, the role of GH, ghrelin, and GHSR1a in the age-associated vulnerability to sepsis remains unknown., Methods: Male Fischer 344 rats (young: 3 months; aged: 24 months) were used. Plasma GH levels, ghrelin receptor expression, and neuronal activity in the parasympathostimulatory nuclei of the brain stem in normal young and aged animals were measured. Endotoxemia was induced by intravenous injection of lipopolysaccharide (LPS, 15 mg/kg BW)., Results: While LPS-induced release of proinflammatory cytokines from macrophages isolated from aged rats decreased, LPS injection resulted in an in vivo hyperinflammatory state. GH levels were lower in aged rats, which was associated with lower expression of GHSR1a in the dorsal vagal complex and a decrease in parasympathostimulatory neuronal activity. GHSR1a antagonist elevated LPS-induced cytokine release in young rats. GH increased GHSR-1a expression in the dorsal vagal complex in aged rats. Coadministration of ghrelin and GH, but not ghrelin alone or GH alone, markedly reduced cytokine levels and organ injury after endotoxemia in aged rats, which was associated with significantly elevated parasympathostimulatory neuronal activity., Conclusions: These findings suggest that the reduced central (brain) responsiveness to ghrelin due to the decreased GH, plays a major role in producing the hyperinflammatory state, resulting in severe organ injuries and high mortality after endotoxemia in aged animals. Ghrelin and GH can be developed as a novel therapy for sepsis in the geriatric population.
- Published
- 2009
- Full Text
- View/download PDF
35. Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.
- Author
-
Manzoni L, Belvisi L, Arosio D, Civera M, Pilkington-Miksa M, Potenza D, Caprini A, Araldi EM, Monferini E, Mancino M, Podestà F, and Scolastico C
- Subjects
- Amides chemistry, Aza Compounds chemistry, Cell Adhesion drug effects, Cells, Cultured, Computer Simulation, Cyclization, Humans, Integrins metabolism, Ligands, Models, Molecular, Molecular Structure, Neoplasms metabolism, Peptides, Cyclic chemistry, Sensitivity and Specificity, Aza Compounds chemical synthesis, Aza Compounds pharmacology, Cycloparaffins chemistry, Integrins antagonists & inhibitors, Neoplasms pathology, Peptides, Cyclic chemical synthesis, Peptides, Cyclic pharmacology
- Abstract
Cyclic RGD-containing functionalized azabicycloalkane peptides were synthesized with the aim of developing high-affinity selective integrin ligands as carriers for therapeutic and diagnostic purposes. Herein we describe the synthesis and in vitro screening of these RGD derivatives, as well as the determination of their conformational properties in solution by spectroscopic and computational methods. Docking studies with the X-ray crystal structure of the extracellular domain of integrin alpha(v)beta(3) were also performed to elucidate the structural binding requirements and to rationalize the biological results. One compound in particular was found to be the best alpha(v)beta(3) integrin binder (IC(50)=53.7 nM) among the new functionalized RGD cyclic peptides, thus emerging as a promising candidate for covalent bonding and selective homing of useful functional units.
- Published
- 2009
- Full Text
- View/download PDF
36. A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester.
- Author
-
Miksa M, Komura H, Wu R, Shah KG, and Wang P
- Subjects
- Animals, Male, Mice, Mice, Inbred C57BL, Microscopy, Fluorescence methods, Rats, Rats, Sprague-Dawley, Spleen cytology, Succinimides chemistry, Thymus Gland cytology, Apoptosis, Flow Cytometry methods, Fluorescent Dyes chemistry, Macrophages, Peritoneal cytology, Phagocytosis physiology
- Abstract
Apoptotic cell phagocytosis has recently raised considerable interest, particularly due to its intricate molecular mechanisms and negative immunologic impact of incompetent clearance of apoptotic cells. There is a need for simple and reliable methods to clearly determine the internalization of apoptotic cells. Labeling with pHrodo succinimidyl ester (SE), a pH-sensitive fluorescent dye, makes engulfed apoptotic cells detectable due to the increased post-phagocytic light emission. This is a valuable tool for phagocytosis studies via FACS. We designed an ex vivo assay, using apoptotic pHrodo-labeled lymphocytes as prey and anti-CD11b-labeled tissue macrophages. To demonstrate its validity of detecting internalized apoptotic lymphocytes, we used MFGE8(-/-) macrophages, known to have impaired phagocytic ability. Uptake of apoptotic lymphocytes was accelerated and enhanced in splenic macrophages after stimulation with recombinant MFGE8, while peritoneal macrophages were able to compensate for the delayed uptake. This novel assay is a quick and reliable method to evaluate the internalization of apoptotic cells.
- Published
- 2009
- Full Text
- View/download PDF
37. Milk fat globule epidermal growth factor-factor VIII is down-regulated in sepsis via the lipopolysaccharide-CD14 pathway.
- Author
-
Komura H, Miksa M, Wu R, Goyert SM, and Wang P
- Subjects
- Animals, Antigens, Surface biosynthesis, Antigens, Surface genetics, Apoptosis immunology, Dose-Response Relationship, Immunologic, Down-Regulation genetics, Endotoxemia metabolism, Endotoxemia pathology, Lipopolysaccharide Receptors genetics, Male, Mice, Mice, Inbred C3H, Mice, Knockout, Mice, Mutant Strains, Milk Proteins biosynthesis, Milk Proteins genetics, Phagocytosis genetics, Phagocytosis immunology, RNA, Messenger antagonists & inhibitors, RNA, Messenger biosynthesis, Signal Transduction genetics, Spleen immunology, Spleen metabolism, Spleen pathology, Down-Regulation immunology, Endotoxemia immunology, Lipopolysaccharide Receptors physiology, Lipopolysaccharides physiology, Milk Proteins antagonists & inhibitors, Signal Transduction immunology
- Abstract
Phagocytosis prevents the release of potentially harmful or immunogenic materials from dying cells. Milk fat globule epidermal growth factor (EGF)-factor VIII (MFG-E8) mediates the clearance of apoptotic cells. We have previously shown that the administration of MFG-E8-rich exosomes from immature dendritic cells promotes the phagocytosis of apoptotic cells and improves survival in sepsis. Because endotoxin is elevated in polymicrobial sepsis, we hypothesized that down-regulation of MFG-E8 is mediated via the LPS-CD14 pathway, eventually leading to the accruement of apoptotic cells. Polymicrobial sepsis was induced by cecal ligation and puncture (CLP) in CD14-deficient (CD14(-/-)), TLR4-mutated and wild-type (WT) mice. In addition, endotoxemia was elicited by i.p. injection of LPS. LPS was also neutralized by pretreating CLP-induced WT mice with polymyxin B. Splenic MFG-E8 expression, phagocytic activity, and apoptosis were assessed 5 and 20 h after CLP or 5 h after LPS administration. In septic WT mice, MFG-E8 mRNA and protein levels were suppressed by 49 and 33%, respectively. Endotoxemia reduced MFG-E8 mRNA expression in a dose dependent manner and the down-regulation of MFG-E8 mRNA expression in CLP-induced sepsis was attenuated by polymyxin B. This CLP-induced suppression was not observed in both CD14(-/-) and TLR4-mutated mice. CLP significantly decreased phagocytic activity of peritoneal macrophages in WT (by 30%), but not in CD14(-/-) mice. CLP also induced significant apoptosis in the spleen of WT (by 61%), but less in CD14(-/-) mice. Thus, MFG-E8 production is down-regulated in sepsis by LPS-CD14 dependent fashion, leading to a reduction of phagocytosis of apoptotic cells.
- Published
- 2009
- Full Text
- View/download PDF
38. Pivotal role of the alpha(2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis.
- Author
-
Miksa M, Das P, Zhou M, Wu R, Dong W, Ji Y, Goyert SM, Ravikumar TS, and Wang P
- Subjects
- Adrenergic alpha-Antagonists pharmacology, Animals, Binding, Competitive, Cecum surgery, Cells, Cultured, Disease Models, Animal, Enzyme Activation drug effects, Gene Expression drug effects, Heart Rate drug effects, Imidazoles administration & dosage, Imidazoles pharmacology, Isoindoles administration & dosage, Isoindoles pharmacology, Kupffer Cells cytology, Kupffer Cells drug effects, Kupffer Cells metabolism, Ligation adverse effects, Liver injuries, Male, Norepinephrine administration & dosage, Norepinephrine pharmacology, Punctures, Radioligand Assay, Rats, Receptors, Adrenergic, alpha-2 genetics, Receptors, Adrenergic, alpha-2 metabolism, Reverse Transcriptase Polymerase Chain Reaction, Sepsis etiology, Sepsis prevention & control, Survival Analysis, Tumor Necrosis Factor-alpha blood, Tumor Necrosis Factor-alpha genetics, Tumor Necrosis Factor-alpha metabolism, p38 Mitogen-Activated Protein Kinases metabolism, Inflammation physiopathology, Liver physiopathology, Receptors, Adrenergic, alpha-2 physiology, Sepsis physiopathology
- Abstract
Background: Norepinephrine (NE) modulates the responsiveness of macrophages to proinflammatory stimuli through the activation of adrenergic receptors (ARs). Being part of the stress response, early increases of NE in sepsis sustain adverse systemic inflammatory responses. The intestine is an important source of NE release in the early stage of cecal ligation and puncture (CLP)-induced sepsis in rats, which then stimulates TNF-alpha production in Kupffer cells (KCs) through the activation of the alpha(2)-AR. It is important to know which of the three alpha(2)-AR subtypes (i.e., alpha(2A), alpha(2B) or alpha(2C)) is responsible for the upregulation of TNF-alpha production. The aim of this study was to determine the contribution of alpha(2A)-AR in this process., Methodology/principal Findings: Adult male rats underwent CLP and KCs were isolated 2 h later. Gene expression of alpha(2A)-AR was determined. In additional experiments, cultured KCs were incubated with NE with or without BRL-44408 maleate, a specific alpha(2A)-AR antagonist, and intraportal infusion of NE for 2 h with or without BRL-44408 maleate was carried out in normal animals. Finally, the impact of alpha(2A)-AR activation by NE was investigated under inflammatory conditions (i.e., endotoxemia and CLP). Gene expression of the alpha(2A)-AR subtype was significantly upregulated after CLP. NE increased the release of TNF-alpha in cultured KCs, which was specifically inhibited by the alpha(2A)-AR antagonist BRL-44408. Equally, intraportal NE infusion increased TNF-alpha gene expression in KCs and plasma TNF-alpha which was also abrogated by co-administration of BRL-44408. NE also potentiated LPS-induced TNF-alpha release via the alpha(2A)-AR in vitro and in vivo. This potentiation of TNF-alpha release by NE was mediated through the alpha(2A)-AR coupled Galphai protein and the activation of the p38 MAP kinase. Treatment of septic animals with BRL-44408 suppressed TNF-alpha, prevented multiple organ injury and significantly improved survival from 45% to 75%., Conclusions/significance: Our novel finding is that hyperresponsiveness to alpha(2)-AR stimulation observed in sepsis is primarily due to an increase in alpha(2A)-AR expression in KCs. This appears to be in part responsible for the increased proinflammatory response and ensuing organ injury in sepsis. These findings provide important feasibility information for further developing the alpha(2A)-AR antagonist as a new therapy for sepsis.
- Published
- 2009
- Full Text
- View/download PDF
39. VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.
- Author
-
Weber P, Wang P, Maddens S, Wang PSh, Wu R, Miksa M, Dong W, Mortimore M, Golec JM, and Charlton P
- Subjects
- Animals, Apoptosis drug effects, Apoptosis immunology, Caspase Inhibitors, Dose-Response Relationship, Drug, Enzyme Inhibitors administration & dosage, Enzyme Inhibitors immunology, Enzyme Inhibitors therapeutic use, Lipopolysaccharides administration & dosage, Lipopolysaccharides blood, Lipopolysaccharides pharmacology, Male, Mice, Models, Animal, Rats, Rats, Sprague-Dawley, Shock, Septic physiopathology, Survival, Treatment Outcome, Caspases drug effects, Enzyme Inhibitors pharmacology, Shock, Septic drug therapy
- Abstract
Introduction: Prevention of lymphocyte apoptosis by caspase inhibition has been proposed as a novel treatment approach in sepsis. However, it has not been clearly demonstrated that caspase inhibitors improve survival in sepsis models when dosed post-insult. Also, there are concerns that caspase inhibitors might suppress the immune response. Here we characterize VX-166, a broad caspase inhibitor, as a novel potential treatment for sepsis., Methods: VX-166 was studied in a number of enzymatic and cellular assays. The compound was then tested in a murine model of endotoxic shock (lipopolysaccharide (LPS), 20 mg/kg IV) and a 10 d rat model of polymicrobial sepsis by caecal ligation and puncture (CLP)., Results: VX-166 showed potent anti-apoptotic activity in vitro and inhibited the release of interleukin (IL)-1beta and IL-18. In the LPS model, VX-166 administered 0, 4, 8 and 12 h post-LPS significantly improved survival in a dose-dependent fashion (P < 0.0028). In the CLP model, VX-166 continuously administered by mini-osmotic pump significantly improved survival when dosed 3 h after insult, (40% to 92%, P = 0.009). When dosed 8 h post-CLP, VX-166 improved survival from 40% to 66% (P = 0.19). Mode of action studies in the CLP model confirmed that VX-166 significantly inhibited thymic atrophy and lymphocyte apoptosis as determined by flow cytometry (P < 0.01). VX-166 reduced plasma endotoxin levels (P < 0.05), suggesting an improved clearance of bacteria from the bloodstream. Release of IL-1beta in vivo or T-cell activation in vitro were moderately affected., Conclusions: Our studies enhance the case for the use of caspase inhibitors in sepsis. VX-166 itself has promise as a therapy for the treatment of sepsis in man.
- Published
- 2009
- Full Text
- View/download PDF
40. Maturation-induced down-regulation of MFG-E8 impairs apoptotic cell clearance and enhances endotoxin response.
- Author
-
Miksa M, Amin D, Wu R, Jacob A, Zhou M, Dong W, Yang WL, Ravikumar TS, and Wang P
- Subjects
- Analysis of Variance, Animals, Antigens, Surface, Apoptosis, Blotting, Western, Down-Regulation, Inflammation chemically induced, Injections, Intraperitoneal, Macrophages, Peritoneal cytology, Mitogen-Activated Protein Kinases metabolism, Rats, Signal Transduction, Thioglycolates administration & dosage, Tumor Necrosis Factor-alpha metabolism, Lipopolysaccharides toxicity, Macrophages, Peritoneal metabolism, Milk Proteins metabolism, Phagocytosis
- Abstract
In sepsis, phagocytosis and the killing of bacteria by phagocytes are important. Similarly, the clearance of accumulating apoptotic cells is critical in maintaining normal immunity. Upon maturation, peritoneal macrophages (PM) become a major source of proinflammatory cytokines, while losing their efficacy of phagocytosis. However, the underlying mechanism remains unknown. Here we investigated the differential effects of apoptotic thymocytes (AoTC) on TNF-alpha release in immature thioglycolate-elicited PM (TGPM) and mature resident PM (RPM) in vitro by culturing them with or without AoTC and/or LPS. MFG-E8 expression was assessed using Western blotting and the ability to engulf AoTC was determined histologically. Cytokine secretion was measured by ELISA. MAP kinase phosphorylation was assessed using Western blotting. Mature RPM express <50% of TGPM MFG-E8 levels and have a 30% lower capacity to clear AoTC. The proinflammatory response (TNF-alpha release) to LPS is 5 times higher, and the capability to phagocytose is decreased along with further down-regulation of MFG-E8 after LPS-stimulation. RPMs also lack phagocytosis-induced inhibition of TNF-alpha release after LPS stimulation. LPS-induced phosphorylation of ERK1/2, p38 and JNK is more enhanced in RPM compared to TGPM. MFG-E8-mediated apoptotic cell phagocytosis results in an inhibition of MAPK and NFkappaB signaling pathways. Differential MAPK activation may play a role in the enhanced LPS responsiveness of RPM and the lack of MFG-E8 impedes post-phagocytic suppression of LPS-response through the inhibition of those signaling pathways. These results provide a potential mechanistic insight into the benefit of promoting apoptotic cell clearance via MFG-E8 under inflammatory conditions.
- Published
- 2008
41. Downregulation of protein disulfide isomerase in sepsis and its role in tumor necrosis factor-alpha release.
- Author
-
Zhou M, Jacob A, Ho N, Miksa M, Wu R, Maitra SR, and Wang P
- Subjects
- Animals, Bacitracin pharmacology, Cell Line, Dose-Response Relationship, Drug, Down-Regulation drug effects, Male, Mice, Rats, Rats, Sprague-Dawley, Sepsis metabolism, Sepsis physiopathology, Down-Regulation physiology, Protein Disulfide-Isomerases antagonists & inhibitors, Protein Disulfide-Isomerases physiology, Sepsis enzymology, Tumor Necrosis Factor-alpha metabolism
- Abstract
Introduction: Protein disulfide isomerase (PDI) is an important factor for the protein modification step in the post-translational event. PDI plays an essential role in cell survival under various stress conditions. It has been reported that PDI can serve as a negative regulator of nuclear factor-kappa-B (NF-kappaB) and that it can inhibit lipopolysaccharide (LPS)-induced proinflammatory cytokine production in macrophages. Thus, PDI may be an intracellular anti-inflammatory molecule. Although we have previously shown that Kupffer cell-derived proinflammatory cytokines cause liver injury in sepsis, the effect of sepsis on PDI expression as well as the effect of PDI inhibition on cytokine production have not been investigated. We therefore hypothesized that sepsis downregulates PDI expression and that the inhibition of PDI promotes proinflammatory cytokine production., Method: Adult male rats were subjected to sepsis by cecal ligation and puncture (CLP) or endotoxemia (continuous infusion of 1 microg/kg body weight LPS by an osmotic pump) for 20 hours. Hepatic tissues were collected and PDI gene expression was determined. In additional experiments, cells from a macrophage-like cell line, RAW 264.7, were treated with 100 ng/mL LPS for 4 hours and protein expressions were measured. RAW 264.7 cells were also treated with bacitracin, a specific PDI inhibitor, for 24 hours, and tumor necrosis factor-alpha (TNF-alpha) gene and protein expression as well as its release in the cell supernatant were determined. To further confirm the beneficial effect of PDI in sepsis, RAW 264.7 cells were transfected with PDI short interfering RNA (siRNA) and PDI gene expression and TNF-alpha release were measured by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay, respectively., Results: PDI gene expression was significantly decreased by 28% and 69% at 20 hours after CLP or LPS infusion, respectively. LPS also decreased PDI protein expression by 33% in RAW 264.7 cells. Incubation of RAW 264.7 cells with bacitracin significantly increased TNF-alpha gene expression and TNF-alpha release as well as its cellular levels in a dose-dependent manner. Transfection of RAW 264.7 cells with PDI siRNA produced an average 36.8% inhibition of the PDI gene expression. This downregulation was correlated with a 3.19-fold increase in TNF-alpha release into the cell supernatant., Conclusion: Taken together, these results suggest that downregulation of PDI by sepsis significantly increases proinflammatory cytokine production. Thus, prevention of PDI downregulation in sepsis may be a novel approach to attenuate hyperinflammation and to reduce tissue injury under such conditions.
- Published
- 2008
- Full Text
- View/download PDF
42. Ghrelin inhibits sympathetic nervous activity in sepsis.
- Author
-
Wu R, Zhou M, Das P, Dong W, Ji Y, Yang D, Miksa M, Zhang F, Ravikumar TS, and Wang P
- Subjects
- Animals, Arginine administration & dosage, Arginine analogs & derivatives, Arginine pharmacology, Disease Models, Animal, Ghrelin administration & dosage, Ghrelin physiology, Injections, Intravenous, Injections, Intraventricular, Male, Norepinephrine administration & dosage, Norepinephrine blood, Norepinephrine pharmacology, Rats, Rats, Sprague-Dawley, Receptors, Ghrelin antagonists & inhibitors, Receptors, Ghrelin physiology, Receptors, Neuropeptide Y antagonists & inhibitors, Receptors, Neuropeptide Y physiology, Sepsis blood, Sepsis metabolism, Signal Transduction drug effects, Substance P administration & dosage, Substance P analogs & derivatives, Substance P pharmacology, Sympathetic Nervous System metabolism, Sympathetic Nervous System physiopathology, Tumor Necrosis Factor-alpha blood, Ghrelin pharmacology, Sepsis physiopathology, Sympathetic Nervous System drug effects
- Abstract
Our previous studies have shown that norepinephrine (NE) upregulates proinflammatory cytokines by activating alpha(2)-adrenoceptor. Therefore, modulation of the sympathetic nervous system represents a novel treatment for sepsis. We have also shown that a novel stomach-derived peptide, ghrelin, is downregulated in sepsis and that its intravenous administration decreases proinflammatory cytokines and mitigates organ injury. However, it remains unknown whether ghrelin inhibits sympathetic activity through central ghrelin receptors [i.e., growth hormone secretagogue receptor 1a (GHSR-la)] in sepsis. To study this, sepsis was induced in male rats by cecal ligation and puncture (CLP). Ghrelin was administered through intravenous or intracerebroventricular injection 30 min before CLP. Our results showed that intravenous administration of ghrelin significantly reduced the elevated NE and TNF-alpha levels at 2 h after CLP. NE administration partially blocked the inhibitory effect of ghrelin on TNF-alpha in sepsis. GHSR-la inhibition by the administration of a GHSR-la antagonist, [d-Arg(1),d-Phe(5), d-Trp(7,9),Leu(11)]substance P, significantly increased both NE and TNF-alpha levels even in normal animals. Markedly elevated circulating levels of NE 2 h after CLP were also significantly decreased by intracerebroventricular administration of ghrelin. Ghrelin's inhibitory effect on NE release was completely blocked by intracerebroventricular injection of the GHSR-1a antagonist or a neuropeptide Y (NPY)/Y(1) receptor antagonist. However, ghrelin's downregulatory effect on TNF-alpha release was only partially diminished by these agents. Thus ghrelin has sympathoinhibitory properties that are mediated by central ghrelin receptors involving a NPY/Y1 receptor-dependent pathway. Ghrelin's inhibitory effect on TNF-alpha production in sepsis is partially because of its modulation of the overstimulated sympathetic nerve activation.
- Published
- 2007
- Full Text
- View/download PDF
43. Vasoactive hormone adrenomedullin and its binding protein: anti-inflammatory effects by up-regulating peroxisome proliferator-activated receptor-gamma.
- Author
-
Miksa M, Wu R, Cui X, Dong W, Das P, Simms HH, Ravikumar TS, and Wang P
- Subjects
- Animals, Cell Line, Cyclic AMP metabolism, Endotoxemia chemically induced, Endotoxemia genetics, Endotoxemia metabolism, Focal Adhesion Kinase 2 metabolism, Inflammation genetics, Inflammation metabolism, Lipopolysaccharides pharmacology, MAP Kinase Signaling System, Male, Mice, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism, PPAR gamma genetics, Rats, Rats, Sprague-Dawley, Tumor Necrosis Factor-alpha metabolism, Adrenomedullin pharmacology, Complement Factor H pharmacology, PPAR gamma metabolism, Up-Regulation drug effects
- Abstract
Sepsis is a critical inflammatory condition from which numerous patients die due to multiple organ failure and septic shock. The vasoactive hormone adrenomedullin (AM) and its binding protein (AMBP-1) are beneficial in sepsis by abrogating the progression to irreversible shock and decreasing proinflammatory cytokine release. To investigate the anti-inflammatory mechanism, we studied to determine the effect of the AM/AMBP-1 complex on peroxisome proliferator-activated receptor-gamma (PPAR-gamma) expression and activation by using RAW264.7 cells and a rat endotoxemia model. LPS treatment significantly decreased PPAR-gamma expression in vivo and in vitro and was associated with increased TNF-alpha production. Treatment with AM/AMBP-1 for 4 h completely restored PPAR-gamma levels in both models, resulting in TNF-alpha suppression. In a knockdown model using small interfering RNA in RAW264.7 macrophages, AM/AMBP-1 failed to suppress TNF-alpha production in the absence of PPAR-gamma. LPS caused the suppression of intracellular cyclic AMP (cAMP), which was prevented by simultaneous AM/AMBP-1 treatment. Although incubation with dibutyryl cAMP significantly decreased LPS-induced TauNuF-alpha release, it did not alter PPAR-gamma expression. Through inhibition studies using genistein and PD98059 we found that the Pyk-2 tyrosine kinase-ERK1/2 pathway is in part responsible for the AM/AMBP-1-mediated induction of PPAR-gamma and the anti-inflammatory effect. We conclude that AM/AMBP-1 is protective in sepsis due to its vasoactive properties and direct anti-inflammatory effects mediated through both the cAMP-dependent pathway and Pyk-2-ERK1/2-dependent induction of PPAR-gamma.
- Published
- 2007
- Full Text
- View/download PDF
44. Fractalkine-induced MFG-E8 leads to enhanced apoptotic cell clearance by macrophages.
- Author
-
Miksa M, Amin D, Wu R, Ravikumar TS, and Wang P
- Subjects
- Animals, Blotting, Western, Cell Line, Chemokine CX3CL1 blood, Enzyme-Linked Immunosorbent Assay, Male, Milk Proteins pharmacology, Phagocytosis drug effects, Rats, Rats, Sprague-Dawley, Recombinant Proteins biosynthesis, Recombinant Proteins pharmacology, Apoptosis physiology, Chemokine CX3CL1 physiology, Macrophages, Peritoneal physiology, Milk Proteins biosynthesis
- Abstract
Clearance of apoptotic cells is crucial to maintain cellular function under normal and pathological conditions. We have recently shown that administration of immature dendritic cell-derived exosomes to septic animals promotes phagocytosis of apoptotic cells and improves survival by providing milk fat globule epidermal growth factor-factor VIII (MFG-E8). MFG-E8 acts as an opsonin for apoptotic cells to be engulfed by phagocytosis. In the present study we investigated whether the CX(3)C-chemokine fractalkine (CX(3)CL1) promotes apoptotic cell clearance through the induction of MFG-E8 in peritoneal macrophages. Cultured rat peritoneal macrophages (pMphi) and RAW264.7 macrophages were stimulated with LPS and CX(3)CL1. MFG-E8 expression was assessed by Western blot, cytokine secretion was assessed by ELISA, and phagocytosis of apoptotic thymocytes was determined by microscopy. For in vivo studies, cecal ligation and puncture (CLP) was used to induce sepsis in rats and mice. LPS significantly decreased MFG-E8 levels and phagocytosis of apoptotic cells, whereas CX(3)CL1 induced MFG-E8 expression in both nonstimulated and LPS-stimulated pMphi, without affecting TNF-alpha and IL-6 release. Anti-MFG-E8 blocking antibodies completely abrogated the prophagocytic effect of CX(3)CL1. Twenty hours after the induction of sepsis in rats via CLP, plasma CX(3)CL1 levels as well as MFG-E8 production in peritoneal macrophages decreased by 21% and 56%, respectively. Administration of CX(3)CL1 on the other hand induced MFG-E8 and prevented tissue injury. We conclude that CX(3)CL1 induces MFG-E8 in vitro and in vivo and enhances clearance of apoptotic cells in an MFG-E8-dependent manner. These findings suggest a possible novel treatment for patients in sepsis.
- Published
- 2007
- Full Text
- View/download PDF
45. Dendritic cell-derived exosomes containing milk fat globule epidermal growth factor-factor VIII attenuate proinflammatory responses in sepsis.
- Author
-
Miksa M, Wu R, Dong W, Das P, Yang D, and Wang P
- Subjects
- Animals, Apoptosis, Autophagy, Cell Line, Inflammation blood, Inflammation pathology, Liver metabolism, Liver pathology, Macrophages, Peritoneal metabolism, Macrophages, Peritoneal pathology, Male, Rats, Rats, Sprague-Dawley, Sepsis pathology, Thymus Gland metabolism, Thymus Gland pathology, Antigens, Surface biosynthesis, Antigens, Surface chemistry, Dendritic Cells chemistry, Dendritic Cells pathology, Milk Proteins biosynthesis, Milk Proteins chemistry, Sepsis blood, Transport Vesicles chemistry
- Abstract
In sepsis, several cell types (e.g., lymphocytes) undergo apoptosis and have the potential to harm the host if not cleared by professional phagocytes. Apoptotic cells display "eat me" signals such as phosphatidylserine that can be readily recognized by phagocytes. For full engulfment of these cells, binding to integrin alpha(v)beta(3), mediated by the bridging protein, milk fat globule epidermal growth factor-factor VIII (MFG-E8), is necessary. We hypothesized that, in sepsis, phagocytosis of apoptotic cells is impaired due to decreased MFG-E8 expression and that adoptive transfer of exosomes containing MFG-E8 is beneficial. Sepsis was induced in rats by cecal ligation and puncture (CLP) and MFG-E8 expression assessed by Western blot 20 h later. Dendritic cells were generated from bone marrow cells, and secreted exosomes were collected and injected into CLP animals. Plasma cytokines (enzyme-linked immunosorbent assay) and thymocyte apoptosis (TC-Ao, annexin V) were assessed. The ability of peritoneal macrophages from septic animals to engulf apoptotic cells was determined in an ex vivo phagocytosis assay. A 10-day survival study was conducted. Cecal ligation and puncture reduced MFG-E8 protein levels in the spleen and liver by 48% and 70%, respectively, and increased TC-Ao by 1.6-fold. Injection of MFG-E8-containing exosomes, however, led to a 33% reduced detection of TC-Ao, without directly inhibiting apoptosis. In fact, peritoneal macrophages from exosome-treated rats displayed a 2.8-fold increased ability to phagocytose apoptotic thymocytes. Inhibition of MFG-E8 before injection of exosomes completely abrogated the enhanced phagocytosis. Treatment with bone marrow dendritic cell-derived exosomes also reduced plasma tumor necrosis factor alpha and interleukin (IL)-6 levels and improved survival from 44% to 81%. We conclude that, by providing the indispensable factor MFG-E8 for complete engulfment of apoptotic cells, these exosomes lead to an attenuation of the systemic inflammatory response and overall beneficial effect in sepsis.
- Published
- 2006
- Full Text
- View/download PDF
46. Sympathetic excitotoxicity in sepsis: pro-inflammatory priming of macrophages by norepinephrine.
- Author
-
Miksa M, Wu R, Zhou M, and Wang P
- Subjects
- Animals, Humans, Macrophages physiology, Immune System physiology, Macrophages drug effects, Norepinephrine pharmacology, Sepsis physiopathology, Sympathetic Nervous System physiology
- Abstract
In the history of medicine, the interaction between mind and body has been repeatedly proposed. However, the influence of the nervous system on the immune regulation has, until now, drawn little attention. In this regard, the adrenergic system has been explored, and mainly catecholamine-mediated anti-inflammatory effects have been described. These inhibitory effects of epinephrine and norepinephrine were found to be mediated by beta2-adrenoceptors expressed on mononuclear cells. Recently, the role of the parasympathetic nervous system in the local anti-inflammatory reflex has been investigated. Stimulation of the vagus nerve decreases the pro-inflammatory response of macrophages via alpha7-cholinergic receptors. Thus, both the sympathetic and parasympathetic nervous systems are thought to work hand in hand in their anti-inflammatory responses. Here we discuss the deteriorating effects of the release of norepinephrine in sepsis. We have discovered that organ dysfunction in severe sepsis is mediated at least in part by an increase in pro-inflammatory cytokine release from Kupffer cells, which is caused by a priming via gut-derived norepinephrine. The sympathetic nervous system and gut-derived norepinephrine mediate the pro-inflammatory effects by activating alpha2A-adrenoceptor on Kupffer cells. In this review, we will focus on the differential function of the noradrenergic system on local and systemic inflammatory responses and the possibilities of the modulation of sympathetic outflow by centrally active inhibitors such as the novel peptide ghrelin or NMDA-receptor blockers. Furthermore, we will introduce the new concept of "sympathetic excitotoxicity in sepsis" characterized by the neurogenic priming of the systemic pro-inflammatory response.
- Published
- 2005
- Full Text
- View/download PDF
47. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.
- Author
-
Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, and Olney JW
- Subjects
- Animals, Brain drug effects, Brain embryology, Brain growth & development, Calcium Channel Blockers pharmacology, Dizocilpine Maleate pharmacology, Dopamine Antagonists pharmacology, Dose-Response Relationship, Drug, Excitatory Amino Acid Antagonists pharmacology, Fetus, Haloperidol pharmacology, Immunohistochemistry, In Situ Nick-End Labeling, Microscopy, Electron, Muscarinic Antagonists pharmacology, Neurons drug effects, Neurons metabolism, Quinoxalines pharmacology, Rats, Receptors, N-Methyl-D-Aspartate metabolism, Scopolamine pharmacology, Apoptosis, Brain cytology, Nerve Degeneration, Neurons cytology, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors
- Abstract
Programmed cell death (apoptosis) occurs during normal development of the central nervous system. However, the mechanisms that determine which neurons will succumb to apoptosis are poorly understood. Blockade of N-methyl-D-aspartate (NMDA) glutamate receptors for only a few hours during late fetal or early neonatal life triggered widespread apoptotic neurodegeneration in the developing rat brain, suggesting that the excitatory neurotransmitter glutamate, acting at NMDA receptors, controls neuronal survival. These findings may have relevance to human neurodevelopmental disorders involving prenatal (drug-abusing mothers) or postnatal (pediatric anesthesia) exposure to drugs that block NMDA receptors.
- Published
- 1999
- Full Text
- View/download PDF
48. [Teeth in children in Czechoslovakia in the first school year].
- Author
-
MIKSA M
- Subjects
- Child, Czechoslovakia, Humans, Dentition
- Published
- 1952
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.